Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalized Antiplatelet Therapy After PCI in ACS
NCT00404781Phase 4Completed
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Jun 2006
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cilostazol in acute coronary syndrome (ACS) and ischemic heart disease (IHD), sponsored by General Hospital of the Northern Theater Command. Primary endpoint: Major adverse cardiac and cerebral events at 1 year. Started Jun 2006; status: completed.
02
Drugs
cilostazol
03
Conditions
acute coronary syndrome (ACS)ischemic heart disease (IHD)
Beyond the preview
Go deeper on NCT00404781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00404781.